JenaValve

JenaValve Technology Inc. is engaged in design, development, manufacturing and marketing of transcatheter aortic valve replacement systems (TAVI) to treat patients with severe aortic stenosis. JenaValve is a privately-held, venture capital backed U.S. corporation with operations in Munich, Germany. The Company's TAVI products are being sold primarily in Europe. Please visit www.jenavalve.com for more information.
Type
Private
HQ
München, DE
Founded
2006
Employees
59 (est)+4%
JenaValve was founded in 2006 and is headquartered in München, DE

JenaValve Locations

München, DE

JenaValve Metrics

JenaValve Summary

Founding Date

2006

Total Funding

$113 M

Latest funding size

$26.5 M

Time since last funding

over 1 year

Investors

We estimate that JenaValve's latest funding round in August 2015 was $26.5 M. In total, JenaValve has raised $113 M
We estimate that JenaValve's current employees are approximately 11% female and 89% male.

JenaValve Company Life

You may also be interested in